Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Study examines the effect on quality of life for parents of children who have the rare bleeding disorder.
When a patient’s own blood is managed as the precious resource it is, patients and the health care system reap the benefits.
The global biotech company has been named one of America's Greatest Workplaces for Diversity in 2024.
CSL and CliniSpan Health partnered on a large-scale survey in 2023 to better understand generational differences related to h…
The National Organization for Rare Disorders (NORD) recently launched new informational resources on genetic testing, which c…
SimplyNano 2, an educational experiment kit for high school students, wins an award in Switzerland. CSL Vifor is among the ma…
The University of Pennsylvania’s Dr. Jim Wilson turned his love of cycling into an annual event that has channeled $17 millio…
Forster, a CSL Centenary Fellow is investigating the microbiome to find better treatments for patients who have inflammatory …
Wearables like smartwatches can capture a lot of health-related information. Researchers plan to assess the value of tracking…
Americas
Asia Pacific
Middle East
Europe
